UPDATE 3-Geron's blood dysfunction drug will get FDA advisers' backing
(Provides panel member’s remark in paragraph 7, analyst remark in paragraph 9)By way of Pratik Jain and Christy SanthoshMarch 14 (Reuters) – Advisers to the U.S. Meals and Drug Management on Thursday